AMP-activated protein kinase and glycogen synthase kinase 3β modulate the severity of sepsis-induced lung injury

Molecular Medicine

Volumn 21, Issue , 2015, Pages 937-950

  Liu, Zhongyu ^a   Bone, Nathaniel ^a   Jiang, Shaoning ^a   Park, Dae Won ^a   Tadie, Jean Marc ^a   Deshane, Jessy ^a   Rodriguez, Cilina Ann ^b   Pittet, Jean Francois ^b   Abraham, Edward ^c   Zmijewski, Jaroslaw W ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; CYTOCHROME C OXIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; METFORMIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE;

ABDOMINAL INFECTION; ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERICIDAL ACTIVITY; BLEEDING; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CHEMOTAXIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; EX VIVO STUDY; IMMUNE DEFICIENCY; INNATE IMMUNITY; MACROPHAGE FUNCTION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHYSICAL TOLERANCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 84975138840     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00198     Document Type: Article

References (69)

1. Deutschman CS, Tracey KJ. (2014) Sepsis: Current dogma and new perspectives. Immunity. 40:463-75.
2. Angus DC, van der Poll T. (2013) Severe sepsis and septic shock. N. Engl. J. Med. 369:2063.
3. Hotchkiss RS, Monneret G, Payen D. (2013) Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13:260-8.
4. Lord JM, et al. (2014) The systemic immune response to trauma: An overview of pathophysiology and treatment. Lancet. 384:1455-65.
5. Wheeler AP, Bernard GR. (2007) Acute lung injury and the acute respiratory distress syndrome: A clinical review. Lancet. 369:1553-64.
6. Force ADT, et al. (2012) Acute respiratory distress syndrome: The Berlin Definition. JAMA. 307:2526-33.
7. Sheu CC, et al. (2010) Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest. 138:559-67.
8. Fink MP, Warren HS. (2014) Strategies to improve drug development for sepsis. Nat. Rev. Drug. Discov. 13:741-58.
9. Standiford TJ, Ward PA. (2016) Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl. Res. 167:183-91.
10. Flierl MA, et al. (2008) Adverse functions of IL-17A in experimental sepsis. FASEB J. 22:2198-205.
11. Bosmann M, Ward PA. (2012) Therapeutic potential of targeting IL-17 and IL-23 in sepsis. Clin. Transl. Med. 1:4.
12. Mariathasan S, et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 430:213-8.
13. Brown KA, et al. (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet. 368:157-69.
14. Kolaczkowska E, Kubes P. (2013) Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13:159-75.
15. Abraham E. (2003) Neutrophils and acute lung injury. Crit. Care Med. 31:S195-9.
16. Hotchkiss RS, Monneret G, Payen D. (2013) Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13:862-74.
17. Gentile LF, et al. (2012) Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. J. Trauma Acute Care Surg. 72:1491-501.
18. Singer M. (2014) The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 5:66-72.
19. Brealey D, et al. (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 360:219-23.
20. Singer M. (2007) Mitochondrial function in sepsis: Acute phase versus multiple organ failure. Crit. Care Med. 35:S441-8.
21. Srivastava A, et al. (2015) MKK3 deletion improves mitochondrial quality. Free Radic. Biol. Med. 87:373-84.
22. Matthay MA. (2015) Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome. Ann. Am. Thorac. Soc. 12 Suppl 1:S54-7.
23. Rocha M, Herance R, Rovira S, Hernandez-Mijares A, Victor VM. (2012) Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect. Disord. Drug Targets. 12:161-78.
24. Hardie DG, Ross FA, Hawley SA. (2012) AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell. Biol. 13:251-62.
25. Eid AA, Lee DY, Roman LJ, Khazim K, Gorin Y. (2013) Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression. Mol. Cell. Biol. 33:3439-60.
26. Colombo SL, Moncada S. (2009) AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem. J. 421:163-9.
27. Chen L, et al. (2009) Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature. 459:1146-9.
28. Woods A, et al. (2003) Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J. Biol. Chem. 278:28434-42.
29. Martin-Montalvo A, et al. (2013) Metformin improves healthspan and lifespan in mice. Nat. Commun. 4:2192.
30. Bannister CA, et al. (2014) Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes. Metab. 16:1165-73.
31. Zhao X, et al. (2008) Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L497-L504.
32. Zmijewski JW, et al. (2008) Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am. J. Respir. Crit. Care Med. 178:168-79.
33. Jian MY, Alexeyev MF, Wolkowicz PE, Zmijewski JW, Creighton JR. (2013) Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 305:L844-L855.
34. Jiang S, et al. (2014) Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury. J. Immunol. 192:4795-803.
35. Tadie JM, et al. (2012) Toll-like receptor 4 engagement inhibits adenosine 5′-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism. Mol. Med. 18:659-68.
36. Xing J, et al. (2013) Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo. Am. J. Pathol. 182:1021-30.
37. Meares GP, Qin H, Liu Y, Holdbrooks AT, Benveniste EN. (2013) AMP-activated protein kinase restricts IFN-gamma signaling. J. Immunol. 190:372-80.
38. Park DW, et al. (2014) GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 307:L735-45.
39. Suzuki T, et al. (2013) Inhibition of AMPK catabolic action by GSK3. Mol. Cell 50:407-19.
40. Jiang S, et al. (2013) Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis. J. Biol. Chem. 288:26013-26.
41. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4:31-6.
42. Rodriguez C, et al. (2009) Sodium nitrite therapy attenuates the hypertensive effects of HBOC-201 via nitrite reduction. Biochem. J. 422:423-32.
43. Zmijewski JW, et al. (2009) Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am. J. Respir. Crit. Care Med. 179:694-704.
44. Latz E, Xiao TS, Stutz A. (2013) Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13:397-411.
45. Ayala A, et al. (2002) Shock-induced neutrophil mediated priming for acute lung injury in mice: Divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol. 161:2283-94.
46. LaRue KE, McCall CE. (1994) A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180:2269-75.
47. McClure C, Brudecki L, Yao ZQ, McCall CE, El Gazzar M. (2015) Processing body formation limits proinflammatory cytokine synthesis in endotoxin-tolerant monocytes and murine septic macrophages. J. Innate Immun. 7:572-83.
48. Sag D, Carling D, Stout RD, Suttles J. (2008) Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181:8633-41.
49. Jeong HW, et al. (2009) Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 296:E955-64.
50. Shalova IN, et al. (2015) Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α. Immunity. 42:484-98.
51. van der Poll T, Opal SM. (2008) Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8:32-43.
52. Tavares-Murta BM, et al. (2002) Failure of neutrophil chemotactic function in septic patients. Crit. Care Med. 30:1056-61.
53. Fossati G, et al. (2003) The mitochondrial network of human neutrophils: Role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J. Immunol. 170: 1964-72.
54. Barbier F, Andremont A, Wolff M, Bouadma L. (2013) Hospital-acquired pneumonia and ventilator-associated pneumonia: Recent advances in epidemiology and management. Curr. Opin. Pulm. Med. 19:216-28.
55. Martin M, Rehani K, Jope RS, Michalek SM. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6:777-84.
56. Rocha J, et al. (2015) Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat. Shock. 43:369-78.
57. Li H, et al. (2013) NF-κB inhibition after cecal ligation and puncture reduces sepsis-associated lung injury without altering bacterial host defense. Mediators Inflamm. 2013:503213.
58. Park DW, et al. (2013) Activation of AMPK enhances neutrophil chemotaxis and bacterial killing. Mol. Med. 19:387-98.
59. Bae HB, et al. (2011) AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils. FASEB J. 25: 4358-68.
60. Mounier R, et al. (2013) AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab. 18:251-64.
61. Labuzek K, Liber S, Gabryel B, Adamczyk J, Okopien B. Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch. Pharmacol. 381:171-86.
62. Zolfaghari PS, et al. (2015) Skeletal muscle dysfunction is associated with derangements in mitochondrial bioenergetics (but not UCP3) in a rodent model of sepsis. Am. J. Physiol. Endocrinol. Metab. 308:E713-25.
63. Japiassu AM, et al. (2011) Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5′-triphosphate synthase activity. Crit. Care Med. 39:1056-63.
64. Mulchandani N, et al. (2015) Stimulation of brain AMP-activated protein kinase attenuates inflammation and acute lung injury in sepsis. Mol. Med. 21:637-44.
65. Mannam P, et al. (2014) MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 306:L604-19.
66. Ward PA. (2011) Immunosuppression in sepsis. JAMA. 306:2618-9.
67. Faubert B, et al. (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17:113-24.
68. Treins C, Murdaca J, Van Obberghen E, Giorgetti-Peraldi S. (2006) AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1. Biochem. Biophys. Res. Commun. 342:1197-202.
69. Metformin in Longevity Study (MILES) [Internet]. (2016) [updated 2015 Dec 8; cited 2016 Jan 29]. Available from: Https://clinicaltrials.gov/ct2/show/record/NCT02432287ClinicalTrials.gov identifier: NCT02432287.